Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Announcement Under Reg. 30 - Disclosure Of Imapact Of Covid-19 Pandemic

 Dear Sir/Ma'am, We take the reference to SEBI Circular dated 20th May, 2020 regarding advisory on disclosure of material impact of Covid-19 Pandemic on listed entities under SEBI (LODR) Regulations, 2015. Please find enclosed prescribed details as per the circular. You are requested to kindly bring the aforesaid news to the investors at large and also to take the same on your record.
29-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Compliance Of Regulation 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2020 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 4th August, 2020 at the registered office to consider following : To consider and approve the appointment of Mr. Hiren Ravindrabhai Shah as an Additional Independent Director of the Company with immediate effect. To consider issue and allot subject to approval of the Shareholders and Stock Exchanges where the Shares of the Company are listed, Convertible warrants on preferential basis, in accordance with Section 42 and 62(1)(c) of the Companies Act, 2013 and all other applicable provisions, if any, (including any statutory modification(s) or re-enactments thereof for the time being in force), Memorandum and Articles of Association of the Company, SEBI (LODR), and in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and also decide the matters consequential thereto. Any other matters with the permission of the Chair.
28-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Compliances - Re-Submssion Of Compliance Certificate As Per Reg. 40(10) Of SEBI LODR, 2015 For The Half Year Ended 31St March, 2020

 Dear Sir/Ma'am, We are re-submitting herewith Compliance Certificate, pursuant to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, issued by a Practicing Company Secretary for the Half Year ended 31st March, 2020 as required from your good office. Further, we would like to inform you that we have submitted the same with SD/- due to Covid-19 pandemic and at that time, we have received a mail communication received from BSE mentioning SD/- will be deemed as sufficient compliance. (mail communication has been attaching herewith) Kindly take the above on your records.
23-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended June 30, 2020

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
10-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Puneeta SharmaDesignation :- Company Secretary and Compliance Officer
06-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Sub: Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018. Dear Sir / Ma'am, We are enclosing herewith the Confirmation Certificate under Re. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2020. Kindly take the above on your record.
03-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

 Sub: Intimation of Closure of Trading Window for Designated persons and immediate relative of Designated Person. Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter ended June 30, 2020. You are requested to disseminate the above information on your website.
03-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In Respect Of Related Party Disclosures

 Dear Sir/Ma'am, As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2020, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty-Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 5,14,50,546/- (Rupees Five Crores Fourteen Lakhs Fifty Thousand Five Hundred and Forty Six only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
01-07-2020
Bigul

Medico Intercontinental Ltd - 539938 - Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., June 30, 2020, inter alia, considered and approved: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and Financial year ended on March 31, 2020 along with Auditors report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Re-Appointment of M/s. Yash Mehta & Associates, Practicing Company Secretary, Ahmedabad as Secretarial Auditor of the Company for the F.Y. 2020-21. 3. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2020-21. Further as per attached file.
30-06-2020
Bigul

Medico Intercontinental Ltd - 539938 - Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., June 30, 2020, inter alia, considered and approved: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and Financial year ended on March 31, 2020 along with Auditors report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Re-Appointment of M/s. Yash Mehta & Associates, Practicing Company Secretary, Ahmedabad as Secretarial Auditor of the Company for the F.Y. 2020-21. 3. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2020-21. Further as per attached file.
30-06-2020
Next Page
Close

Let's Open Free Demat Account